α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. α-Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing α-synuclein–GFP. Images shown are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with α-synuclein overexpression or Rab1a knockdown. Golgi fragmentation can be seen in the p230 columns. α-Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocalization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of endogenous Atg9 and LC3 in cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing α-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) (D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or α-synuclein overexpression (*, P < 0.05; **, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.](https://figures.cochat.ai/paper-figures/72d18dd1e8114fddb91346cb34772324/synuclein-impairs-macroautophagy-implications-for-parkinsons-disease-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathologically meaningful levels of SNCA/α‐synuclein affect the intracellular localization of ATG9 via RAB1A (RAB1A, member RAS oncogene family), thereby perturbing autophagy dynamics in the brain of transgenic mice overexpressing SNCA/α‐synuclein (Winslow et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Winslow et al, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, overexpression of wild-type synuclein impairs autophagic activity, implying a functional relationship between synuclein and autophagic degradation19.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 2×
“Further lipidation of LC3-I creates the autophagosome-associated form, LC3-II, which is known to be a robust marker of autophagosomes (Kabeya et al., 2000).”
A guided tour into subcellular colocalization analysis in light microscopy
BOLTE, S., & CORDELIÈRES, F. P. (2006) · Journal of Microscopy · doi:10.1111/j.1365-2818.2006.01706.x · Cited by 5,324 · cited 1×
“Cells were imaged in z stacks, and images were analyzed by the JaCoP plugin (Bolte and Cordelières, 2006) in the ImageJ software.”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“In addition to the accumulation of aggregate-prone proteins, the cells will not be as effective in clearing dysfunctional mitochondria (Twig et al., 2008) and will have increased susceptibility to certain apoptotic insults (Ravikumar et al., 2006); these are all processes that have been implicated…”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Mice defective for macroautophagy die soon after birth, and neuronal knockouts of such genes cause neurodegeneration accompanied by inclusion formation (Kuma et al., 2004; Komatsu et al., 2005).”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 2×
“In this sense, the percentage of cells with mutant huntingtin aggregation can serve as a sensitive indicator of autophagic substrate clearance (Klionsky et al., 2008).”
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118 · cited 1×
“62 (Jackson et al., 1998) with flies expressing wild-type -synuclein (UAS--syn; Feany and Bender, 2000) and with flies expressing constitutively active Rab1 (y1 P{UASp-YFP.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 8×
“Vol. 190 No. 6 1023–1037 www.jcb.org/cgi/doi/10.1083/jcb.201003122 JCB 1023 Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: ANOVA, analysis of variance; CMA, chaperonemediated autophagy; HD, Huntington’s disease; PD, Parkinson’s disease; PI(3)P, phosphatidylinositol-3…”
InfluentialAxe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 2×
“Thus, cells expressing GFP-labeled DFCP1 allow for the visualization of early events in autophagosome formation (Axe et al., 2008).”
Cited by
Items 601–700 of 826
Collins, L., Drouin‐Ouellet, J., Kuan, W., Cox, T. M., & Barker, R. A. (2017) · F1000Research · doi:10.12688/f1000research.12090.1 · Cited by 9
Amireddy, N., Dulam, V., Kaul, S., Pakkiri, R., & Kalivendi, S. V. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110769 · Cited by 9
A candidate loss-of-function variant in SGIP1 causes synaptic dysfunction and recessive parkinsonism
Decet, M., Scott, P., Kuenen, S., Meftah, D., Swerts, J., Calatayud, C., Gallego, S. F., Kaempf, N., Nachman, E., Praschberger, R., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101749 · Cited by 11
Trisal, A., & Singh, A. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.004 · Cited by 9
Tong, S., Wang, R., Li, H., Zhu, T., Geng, D., Zhang, X., & Ren, C. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111272 · Cited by 8
Bonavita, R., Vitale, F., Verdicchio, L. V., Williams, S. V., Caporaso, M. G., Fleming, A., & Renna, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1538377 · Cited by 9
The role of autophagy in synucleinopathy: clearance versus spread of α-synuclein
Birnbaum, E., & Yue, Z. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2577406 · Cited by 14
“Both findings support the idea that α-synuclein suppresses autophagy by impairing formation of the autophagosome (Figure 1) [143] .”
Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases
Koçak, G., Dimas, M. M., Silva, L., Silva-Amaral, D., Sun, C., Cruddas, S., Barrett, T. G., Martins‐de‐Souza, D., Cunha‐Neto, E., Brocardo, P. S., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695486 · Cited by 8
Jin, J., Cen, Q., Wang, H., Xin, Y., Feng, J., Cui, Y., Li, J., You, Z., Jing, F., Yu, Y., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107283 · Cited by 12
Genetically encoded fluorescent reporters to visualize α-synuclein pathology in live brain
Zhang, L. I., Yu, M., Chen, G., Ge, S., Wang, M., Zhang, X., Zhao, M., Gu, H., Huang, M., Liu, A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.035 · Cited by 12
Autophagy and Cell Death in Alzheimer’s, Parkinson’s and Prion Diseases
Ribarič, S., & Milisav, I. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.86706 · Cited by 10
Coles, N. P., Elsheikh, S., Quesnel, A., Butler, L., Achadu, O. J., Islam, M., Kalesh, K., Occhipinti, A., Angione, C., Marles‐Wright, J., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf133 · Cited by 10
“27 Similarly, in SH-SY5Y cells, high molecular weight (HMW) α -synuclein oligomers have been shown to disrupt cellular membranes, triggering caspase-dependent apoptosis.”
Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells
Nandakumar, S., Vijayan, B., Kishore, A., & Thekkuveettil, A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0402-x · Cited by 9
“Additionally, overexpression of α-syn has also been shown to block macroautophagy (Winslow et al. 2010).”
InfluentialParkinson's disease and microRNAs - Lessons from model organisms and human studies
Evans, B., Furlong, H. A., & de Lencastre, A. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111585 · Cited by 9
The molecular pathology of neurodegenerative and psychiatric disorders
Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 9
A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0519-7 · Cited by 8
“Aberrant α-synuclein can also inhibit macroautophagy in experiments on cell cultures and animal models of PD [Winslow et al., 2010].”
Research progress of T cell autophagy in autoimmune diseases
Zhao, X., Ma, D., Yang, B., Wang, Y., & Zhang, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425443 · Cited by 13
Noda, S., Sato, S., Yamakado, H., Takahashi, R., & Hattori, N. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151514 · Cited by 7
Advances in autophagy for Parkinson’s disease pathogenesis and treatment
Zhang, X., Zhang, H., Dong, J., Cai, H., & Le, W. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.33 · Cited by 16
Abubakar, M., Alom, S., Ali, F., Ali, S. R., Adhikary, K., Sarika, S., Gupta, P. K., Puppala, E. R., Murti, K., Nand, S., et al. (2026) · Current Neuropharmacology · doi:10.2174/011570159x446831260303200516 · Cited by 9
“As an example, autophagy is inhibited when α-syn is overexpressed [181].”
Herrera, A., Packer, M. M., Rosas‐Lemus, M., Minasov, G., Chen, J., Brumell, J. H., & Satchell, K. J. F. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316143121 · Cited by 6
Quantitative Flow Cytometry-Based Assays for Measuring Constitutive Secretion
Gordon, D. E., Shun-Shion, A. S., Asnawi, A. W. A., & Peden, A. A. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1044-2_8 · Cited by 7
Self-citationYang, F., An, R., Zhang, Y., Chen, M., Wang, L., Duan, Y.-Y., & Xing, C. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122351 · Cited by 7
Lenzi, P., Lazzeri, G., Ferrucci, M., Scotto, M., Frati, A., Puglisi‐Allegra, S., Busceti, C. L., & Fornai, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073929 · Cited by 7
Drosophila as a model to understand autophagy deregulation in human disorders
Denton, D., O’Keefe, L. V., & Kumar, S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.01.005 · Cited by 9
Osumi, N., & Kikkawa, T. (2013) · Springer eBooks · doi:10.1007/978-4-431-54496-8_3 · Cited by 9
Toxic mechanisms of amyloid oligomers and therapeutic strategies
Ivanova, M. I., Rosa, C. L., & Ramamoorthy, A. (2026) · Protein Science · doi:10.1002/pro.70519 · Cited by 6
Importance of DJ-1 in autophagy regulation and disease
Liu, S., Xu, S., Liu, S., & Chen, H. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109672 · Cited by 6
Protein Misfolding and Aggregation: Implications for Mitochondrial Dysfunction and Neurodegeneration
Ludtmann, M. H. R., & Abramov, A. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_10 · Cited by 6
Pathways of protein synthesis and degradation in PD pathogenesis
Langston, R. G., & Cookson, M. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.002 · Cited by 9
Macías‐Calvio, V., Fuentealba, L., & Marzolo, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24675 · Cited by 7
“…et al., 2011), protein misfolding (Spillantini et al., 1997; Spillantini, Crowther, Jakes, Hasegawa, & Goedert, 1998), malfunction of macroautophagy (Winslow et al., 2010), and chaperone-mediated autophagy (CMA) (Xilouri, Vogiatzi, Vekrellis, Park, & Stefanis, 2009), and tau protein…”
Kim, B., Jang, T., Yoo, S., Lee, J. M., & Kim, E. (2021) · The FASEB Journal · doi:10.1096/fj.202001371rr · Cited by 7
Parkinson’s Disease: Basic Pathomechanisms and a Clinical Overview
Noyce, A. J., & Bandopadhyay, R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_3 · Cited by 7
Amyloid-like aggregates cause lysosomal defects in neurons via gain-of-function toxicityPreprint
Riera-Tur, I., Schäfer, T., Hornburg, D., Mishra, A., Fernández-Mosquera, L., Feigenbutz, D., Auer, P., Mann, M., Baumeister, W. P., Klein, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.16.877431 · Cited by 6
“Conversely, aggregating proteins themselves might directly interfere with the normal function of the autophagy-lysosomal machinery (Cuervo et al., 2004; Winslow et al., 2010; Wong and Holzbaur, 2014).”
BackgroundWang, Y., Gao, P.-P., Wu, Z., Jiang, B., Wang, Y., He, Z., Zhao, B., Tian, X., Gao, H., Cai, L., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119095 · Cited by 9
Chakraborty, R., Palese, F., Samella, P., Testa, V., Montero-Muñoz, J., Syan, S., Nonaka, T., Hasegawa, M., Consiglio, A., & Zurzolo, C. (2026) · Nature Communications · doi:10.1038/s41467-026-69930-y · Cited by 13
Fomin, M., Zapf, K., Schieffer, E., Freitag, J., Bange, G., & Schieffer, B. (2026) · Inflammation Research · doi:10.1007/s00011-026-02283-w · Cited by 6
“In Parkinson disease (PD), lipid droplets can act as nucleation sites for α-synuclein aggrega - tion, while modified α-synuclein inhibits chaperone-medi - ated autophagy and disrupts macroautophagy through ATG9 and RAB1A, thereby impairing lysosomal clearance and lipophagy [117–120].”
Multiple tethers of organelle contact sites are involved in α-synuclein toxicity in yeast
Vecchio, M. D., Amado, L., Cogan, A. P., Meert, E. M. K., Rosseels, J., Franssens, V., Govers, S. K., Winderickx, J., & Montoro, A. G. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-01-0029 · Cited by 5
George, J., Shafiq, K., Kapadia, M., Kalia, L. V., & Kalia, S. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-64131-3 · Cited by 7
“This contributes to a vicious cycle of further accumulation 47 and increased autophagic impairment 48–51 .”
BackgroundEffects of caloric restriction on retinal aging and neurodegeneration
Adornetto, A., Morrone, L. A., Satriano, A., Laganà, M. L., Licastro, E., Nucci, C., Corasaniti, M. T., Tonin, P., Bagetta, G., & Russo, R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.07.005 · Cited by 6
Rajasekaran, S., Patel, D., & Witt, S. N. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.101 · Cited by 6
Abnormal Vacuole Membrane Protein-1 Expression in Parkinson’s Disease Patients
Al‐Nusaif, M., Cheng, C., Li, T., Jia, C., Wang, P., Li, S., & Le, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.760932 · Cited by 5
“The amount of α-synuclein in DAergic neurons is an important determinant of neurotoxicity in PD; therefore, effective α-synuclein clearance is an essential determinant of PD severity (Winslow et al., 2010).”
BackgroundSeo, D.-C., Ju, Y. H., Seo, J.-J., Oh, S., Lee, C. J., Lee, S. E., & Nam, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032491 · Cited by 6
“For instance, dysfunctional autophagy-lysosome system [5], synucleinopathy-associated endoplasmic reticulum (ER) stress [6–8], disturbance in mitochondrial function [9], and dysregulated calcium homeostasis [10,11] have been considered to contribute to the DA neuronal death.”
BackgroundKon, T., Lee, S., Martínez-Valbuena, I., Yoshida, K., Tanikawa, S., Lang, A. E., & Kovács, G. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052676 · Cited by 5
Neuronal Autophagy Failure Drives α-Synuclein Transfer to Microglia to Outsource Aggregate ClearancePreprint
Chakraborty, R., Samella, P., Testa, V., Montero-Muñoz, J., Nonaka, T., Hasegawa, M., Consiglio, A., & Zurzolo, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.19.590207 · Cited by 5
“…compromised macroautophagy (henceforth referred to as “autophagy”) or chaperone-mediated autophagy (CMA) in PD: impaired autophagosome formation (Winslow et al , 2010), dysregulated mitophagy due to mutations in genes encoding PTEN-induced putative kinase 1 ( PINK1 ) and Parkin RBR E3…”
Gao, H., Liang, Y., Wang, M., Li, W., Zheng, W., Wang, Z., Sun, G., Liu, M., Liu, M., & Zhang, Y. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177774 · Cited by 6
The α-synuclein proteostasis network and its translational applications in Parkinson’s disease
Lim, C. M., & Vendruscolo, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2513317123 · Cited by 5
“This str ucture of the α-S yn PN is consistent with previous reports indicating that a reduced ability to degrade damaged or misfolded α-S yn is a driver of α-Sy n aggregation in PD and related synucleinopathies (26–28), and it represents a possible therapeutic target (8, 18, 29).”
Okatsu, K., Kikuchi, R., Matsuda, N., Fukai, S., & Yamano, K. (2025) · Genes to Cells · doi:10.1111/gtc.70043 · Cited by 4
“The interaction with OPTN was specific for RAB8 family proteins since other RAB proteins, including RAB1A/B and RAB11A/B, which have been reported to be involved in autophagy (Puri et al. 2018; Winslow et al. 2010), could not form fluoppi foci with OPTN (Figure 1D,E).”
Protein Translation in Parkinson’s Disease
Kim, J. W., Abalde-Atristain, L., Jia, H., Martin, I., Dawson, T. M., & Dawson, V. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00009-2 · Cited by 4
Grouper Rab1 inhibits nodovirus infection by affecting virus entry and host immune response
Guan, L., Wen, X., Zhang, Z., Wang, L., Zhang, X., Wang, S., Wang, S., & Qin, Q. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109136 · Cited by 4
Autophagic Flux Failure in Neurodegeneration: Identifying the Defect and Compensating Flux Offset
Ntsapi, C., Swart, C., Lumkwana, D., & Loos, B. (2016) · InTech eBooks · doi:10.5772/64197 · Cited by 4
“Aberrant α‐ synuclein not only inhibits CMA but also inhibits autophagy [48], while the overexpression of α‐synuclein blocks autophagosome formation [49].”
BackgroundGuseo, A. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29461 · Cited by 6
Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection
Gleave, J. A., Perri, P. D., & Nash, J. E. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1337-8 · Cited by 5
“Misfolded forms of mutant α -synuclein that are linked with PD have a direct dysfunctional effect on the UPS, autophagy, and CMA function (Snyder et al., 2003; Xilouri et al., 2009; Winslow et al., 2010; Zhang et al., 2008).”
α-Synuclein impairs macroautophagy: implications for Parkinson's disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo‐Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem20710oia29 · Cited by 4
Self-citationXin, W., Wei, W., Luo, X., Hao, Z., Zhang, L., Zeng, Y.-M., Wan, H., Yang, S., Shang, X., Li, M., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149187 · Cited by 6
Lee, S. H., Han, J. W., Yoon, S.-A., Chang, H. S., & Park, T. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021031 · Cited by 3
“Several studies have suggested that impairments in autophagy may contribute to the development of Alzheimer’s disease [28–30], Parkinson’s disease [31,32], and amyotrophic lateral sclerosis [33,34].”
Exploring the intersecting paths between metabolic disorders and neurological manifestations
Eissa, N., Chkier, D., Ahmed, A., Attia, R. T., Zia, M., Beiram, R., & Sadek, B. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e44658 · Cited by 3
Shimizu, T., Isik, S., Kamath, N., & Yue, Z. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00555-3 · Cited by 4
Ranjan, P. (2026) · Bioscience Reports · doi:10.1042/bsr20260364 · Cited by 3
“In parallel, aging-associated decline in protein homeostasis mechanisms, particularly autophagy and lysosomal degradation pathways, reduces the efficient clearance of aberrant α -Syn species, thereby facilitating their accumulation and aggregation [146–148].”
Autophagic mechanisms in longevity intervention: role of natural active compounds
Akça, K. T., Ayan, İ. Ç., Çetinkaya, S., Salihoğlu, E. M., & Süntar, I. P. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.5 · Cited by 4
How coat proteins shape autophagy in plant cells
Chung, T., Choi, Y. E., Song, K., & Jung, H. (2024) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiae426 · Cited by 4
New Atg9 Phosphorylation Sites Regulate Autophagic Trafficking in Glia
Wang, L., Yi, S., Zhang, S., Tsai, Y.-T., Cheng, Y.-H., Lin, Y.-T., Lin, C.-C., Lee, Y., Wang, H., & Ho, M. S. (2025) · ASN NEURO · doi:10.1080/17590914.2024.2443442 · Cited by 3
“As Atg9 dysregulation has been implicated in PD (Winslow et al., 2010; Yang et al., 2022; Yi et al., 2024), we tested whether Atg9 phosphorylation at T62 and T69 contributes to locomotor function and DA neurodegeneration in flies.”
Degradation of Misfolded Proteins in Neurodegenerative Diseases: Therapeutic Targets and Strategies
Rajak, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_17 · Cited by 4
Movement disorders: new insights into Parkinson's disease
Stoessl, A. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70303-3 · Cited by 3
Mitochondrial Degradation, Autophagy and Neurodegenerative Disease
Otten, E. G., Manni, D., & Korolchuk, V. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_11 · Cited by 5
Autophagy Mechanisms for Brain Recovery. Keep It Clean, Keep It Alive
Viscomi, M. T., D’Amelio, M., Nobili, A., Cavallucci, V., Latini, L., Bisicchia, E., Sasso, V., & Molinari, M. (2017) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-52067-4_2 · Cited by 4
“Overexpression of a-synuclein impairs autophagy by inhibiting the small GTPase Rab-1A (Winslow et al. 2010), which has an important role in autophagosome biogenesis, and an abundance of a- synuclein induces a mislocalization of an early acting part of the autophagy machinery blocking the formation…”
BackgroundTherapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease
Wei, J., Ho, G. J., Takamatsu, Y., Masliah, E., & Hashimoto, M. (2021) · Parkinson s Disease · doi:10.1155/2021/6318067 · Cited by 3
“Yet, a number of reports show that αS is detrimental to protein degradation systems, such as ubiquitin-proteasome and autophagy, under neurodegenerative conditions in aging [66,67], but there are few studies assessing the effect of αS on protein degradation systems during development/reproduction.”
BackgroundLin, Y., Huang, C., Tsai, B. C., Kumar, K. A., Hsieh, D. J., Chiu, P., Chang, Y., Ho, T., Kuo, W., & Ju, D. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105874 · Cited by 4
Liang, Y., Zhong, G., Li, Y., Ren, M., Wang, A., Ying, M., Liu, C., Guo, Y., & Zhang, D. (2024) · Biochemical Genetics · doi:10.1007/s10528-023-10652-x · Cited by 3
“However, the aggregated α-syn eventually disrupts the autophagic mechanism (Winslow et al. 2010; Winslow and Rubinsztein 2011).”
Liu, Y., Qin, K., Dou, K., Ren, J., Hou, B., & Xie, A. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167553 · Cited by 5
Autophagy, the “Master” Regulator of Cellular Quality Control: What Happens when Autophagy Fails?
Raquel, A., Catarina, R. A., & Morais, S. (2013) · InTech eBooks · doi:10.5772/55196 · Cited by 4
Nadiminti, S. S. P., Kamak, M., & Koushika, S. P. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0961-5 · Cited by 3
Saraste, J., & Marie, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.20013-8 · Cited by 4
“Moreover, Ypt1/Rab1 is a key regulator of autophagy in yeast and mammals (Lynch-Day et al. 2010; Winslow et al., 2010; Zoppino et al., 2010; Huang et al., 2011; Lipatova et al., 2012).”
BackgroundNoda, S., & Hattori, N. (2025) · Molecular Brain · doi:10.1186/s13041-025-01235-5 · Cited by 2
Mukhtar, S., Kataria, S., Cimaglia, G., & Beccano-Kelly, D. A. (2025) · Current Research in Physiology · doi:10.1016/j.crphys.2025.100166 · Cited by 2
“…of the EndoA risk variants cause a reduction in biogenesis, and α -synuclein overexpression can inhibit autophagosome formation via Rab1a inhibition (Winslow et al., 2010), the others presented here increase biogenesis or halt autophagosome maturation, and are still associated with PD pathogenesis.”
Gong, F., & Cheng, Q. (2026) · Cell Death and Disease · doi:10.1038/s41419-025-08213-8 · Cited by 3
“Taken together, these fi ndings suggest that calcium overload activates TLK2 via phosphorylation, increasing its kinase activity and leading to mitochondrial damage and lysosomal dysfunction, resulting in cell death.”
Dopamine and Rotenone Modulate α‐Synuclein Phase Separation and Liquid to Solid Transition
Bera, R., Manna, S., Shaw, R., Bhattacharyya, A., & Maji, S. K. (2026) · Small · doi:10.1002/smll.202514922 · Cited by 4
FAM48A mediates compensatory autophagy induced by proteasome impairment
Arata, Y., Watanabe, A., Motosugi, R., Iemura, S., Natsume, T., Mukai, K., Taguchi, T., Hirayama, S., Hamazaki, J., & Murata, S. (2019) · Genes to Cells · doi:10.1111/gtc.12708 · Cited by 5
“Disturbance of protein homeostasis has deleterious effects including cancer, neurodegeneration and aging (Bence, Sampat, & Kopito, 2001; Song et al., 2014; Tanik, Schultheiss, Volpicelli‐Daley, Brunden, & Lee, 2013; Tseng, Green, Chan, Blurton‐Jones, & LaFerla, 2008; Wang et al., 2016; Winslow et al., 2010; Yan et al.…”
BackgroundXCT 790 is a pharmacological aggrephagy inducer in a yeast model of proteotoxicity
Suresh, S., Rao, M. J., & Manjithaya, R. R. (2021) · Cell Biology International · doi:10.1002/cbin.11518 · Cited by 2
“It is reported that α‐synuclein protein aggregates block autophagy at the autophagosome biogenesis stage (Winslow et al., 2010).”
BackgroundAutophagy and Parkinson’s Disease
Ryan, L., Rob, M., He, J., & Rubinsztein, D. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_242 · Cited by 4
Self-citationActinomyces viscosus promotes neuroprotection in C. elegans models of Parkinson’s disease
Ngana, G. S., Bernardo, M. A. D., Surette, M. G., & MacNeil, L. T. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112061 · Cited by 4
“As with other neurodegenerative diseases, decreased proteostasis is observed in PD (Lindersson et al., 2004; Winslow et al., 2010; Malkus and Ischiropoulos, 2012).”
Tedeschi, V., Ciancio, R., Magliocca, G., Esposito, E., Piccirillo, S., Rubino, V., Preziuso, A., Spadoni, T., Muraglia, N. D., Ruggiero, G., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117219 · Cited by 4
Neurodegenerative Diseases and Autophagy
Fleming, A., Vicinanza, M., Renna, M., Puri, C., Ricketts, T., Füllgrabe, J., López, A., de Jager, S., Ashkenazi, A., Tanasa, M. P., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00011-0 · Cited by 4
Self-citationSystematic interaction mapping reveals novel modifiers of neurodegenerative disease processes
Russ, J. (2012) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/16631 · Cited by 3
Gong, F., Chen, H., Xiong, Y., Cai, R., Zhang, J., Wang, N., & Liu, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.17.500360 · Cited by 2
Lee, Y. J., Syed, K. M., Busquets, O., Li, H., Dunnack, J., Bateup, H. S., Soldner, F., Hockemeyer, D. F., & Rio, D. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582420 · Cited by 3
Gawor, K., Tomé, S. O., Vandenberghe, R. R., Damme, P. V., Vandenbulcke, M., Otto, M., Arnim, C. A. F. V., Ghebremedhin, E., Ronisz, A., Ospitalieri, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.599515 · Cited by 2
“69,70 Thus, the neurodegenerative impact of αSyn might results, at least partially, from its ability to enhance Tau and TDP-43 pathology, form more toxic fibrils with TDP-43, or directly disrupt cellular processes.”
BackgroundAsiago, J. M., Doyle, T. B., Mishra, V. R., Jacquet, A. D. R., & Rochet, J. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00325 · Cited by 1
Astrocytes and the Synucleinopathies
Koob, A. O., & Sacchetti, P. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_8 · Cited by 1
A Balance Between Autophagy and Other Cell Death Modalities in Cancer
Gorbunova, A. S., Kopeina, G. S., & Zhivotovsky, B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2071-7_1 · Cited by 1
Autophagy Mechanisms for Brain Recovery. Keep It Clean, Keep It Alive
Nobili, A., Barbera, L. L., Mastrantonio, R., Palazzo, C., Molinari, M., D’Amelio, M., & Viscomi, M. T. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24930-3_2 · Cited by 1
Rab1A functioned as a binding protein involved in Macrobrachium rosenbergii Taihu virus infection
Tan, R., Shen, J., Xu, T., & Pan, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109239 · Cited by 1
MicroRNAs and synaptic dysfunction in Parkinson’s disease
Ogwo, M. N., Sharma, B., Goyal, G., Lakshmanaswamy, R., & Kumar, S. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102673 · Cited by 3
Kaur, N., & Aran, K. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10944-y · Cited by 2
Toxic Tango in Parkinson's Disease: A dance between αSyn and iron import, export and speciation
Cosson, T., Faller, P., & Pountney, D. L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106053 · Cited by 1
Dobria, A., Suarez, A. A., Whitmarsh‐Everiss, T., Pavlinov, I., Soliz, V., Hippman, R. S., Petersson, T., Petros, Z. A., & Aldrich, L. N. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00780 · Cited by 1
Zuo, X., Chen, Z., Chen, X., Guan, D., Shaw, P. X., Johnstone, A. D., Becker, A., Das, U., & Mobley, W. C. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01382-z · Cited by 2
The role of energy deficit in autophagy failure in Parkinson’s disease
Bošnjak, M., Misirkic-Marjanovic, M., Kosić, M., Mandić, M., Vucicevic, L. M., Paunović, V., & Harhaji-Trajkovic, L. M. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1846307 · Cited by 2
Noda, S., & Hattori, N. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1924943 · Cited by 1
“Intracellular protein quality-control systems, particularly the autophagy–lysosome pathway, are central to maintaining α -syn homeostasis (6, 7, 16–20).”
Fu, J., Zhu, C., & Fan, Z. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1885103 · Cited by 1
“…related synucleinopathy models, impairment of macroautophagy has been implicated as an important contributor to α -Syn accumulation, impaired proteostasis, and neuronal vulnerability (Figure 5; Huang et al., 2012; Spencer et al., 2009; Tang et al., 2021; Webb et al., 2003; Winslow et al., 2010).”
Influential
Metadata
- Authors
- Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., Brown, S., O’Kane, C. J., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Medical Research Council (GB)
- Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire OX11 0RD, England, UK 4
- Corresponding author
- Rubinsztein, David C.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 1023-1037
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3101586
- OpenAlex
- W2142047537
- Cited by
- 825
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 55 · 2023: 45 · 2022: 42 · 2021: 51 · 2020: 66 · 2019: 72 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 53 · 2014: 37 · 2013: 43 · 2012: 51
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (FP7/2007–2013, 089703)
- European Commission (241791)
- Cambridge Trust
- Medical Research Council (MC_G1000734)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, macroautophagy, Parkinson's disease, Rab1A, Atg9, Lewy bodies, transgenic mice
- MeSH terms
- Animals, Autophagy, Drosophila melanogaster, Golgi Apparatus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Models, Biological, Parkinson Disease, Phagosomes, rab1 GTP-Binding Proteins, Protein Transport, Secretory Vesicles, Cell Line, Tumor, Mice, alpha-Synuclein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.